Harbour Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$137K Buy
696
+264
+61% +$51.3K ﹤0.01% 1745
2025
Q4
$75K Sell
432
-854
-66% -$156K ﹤0.01% 1768
2025
Q3
$245K Sell
1,286
-4
-0.3% -$710 0.01% 1150
2025
Q2
$232K Buy
1,290
+53
+4% +$9.21K 0.01% 1105
2025
Q1
$209K Buy
1,237
+37
+3% +$6.08K 0.01% 1078
2024
Q4
$181K Buy
1,200
+2
+0.2% +$311 0.01% 1095
2024
Q3
$186K Buy
1,198
+3
+0.3% +$448 0.01% 1039
2024
Q2
$164K Buy
1,195
+2
+0.2% +$274 0.01% 1019
2024
Q1
$159K Sell
1,193
-9
-0.7% -$1.17K 0.01% 1012
2023
Q4
$166K Buy
1,202
+537
+81% +$70.6K 0.01% 933
2023
Q3
$81K Buy
665
+1
+0.2% +$133 ﹤0.01% 1128
2023
Q2
$93.3K Buy
664
+1
+0.2% +$138 ﹤0.01% 1087
2023
Q1
$93.8K Sell
663
-24
-3% -$3.43K 0.01% 1073
2022
Q4
$107K Buy
687
+27
+4% +$3.88K 0.01% 981
2022
Q3
$88K Hold
660
0.01% 1028
2022
Q2
$88K Buy
+660
New +$89.9K 0.01% 1028
2021
Q4
$124K Sell
715
-1,155
-62% -$176K 0.01% 884
2021
Q3
$272K Buy
1,870
+366
+24% +$53.6K 0.01% 872
2021
Q2
$199K Buy
1,504
+20
+1% +$2.62K 0.01% 1047
2021
Q1
$191K Buy
+1,484
New +$183K 0.01% 985

Other funds holding DGX

Harbour Investments's DGX Position: Q1 2026 in Review

Harbour Investments increased its Quest Diagnostics (DGX) stake by 61% in Q1 2026, buying an estimated $51.3K and bringing the position to 696 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #1745.

Harbour Investments first reported a position in DGX in Q1 2021 and has held it in 20 quarters since. The position peaked at $272K in Q3 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Harbour Investments held 696 shares of Quest Diagnostics worth $137K as of Q1 2026.
  • Harbour Investments bought 264 Quest Diagnostics shares in Q1 2026, an estimated $51.3K.
  • Quest Diagnostics made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #1745 holding.
  • Harbour Investments first reported a position in Quest Diagnostics in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Quest Diagnostics position peaked at $272K in Q3 2021.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.